Search
Sumario de resultados
TIpos de contenido
Fecha
-
EventBIOTRINITY
-
-
EventRESI JPM
-
-
CompanyBRAND COMUNICACION
-
-
CompanyNEURAL OMEGA
-
CompanyBEPHARMA INSTITUTE
-
Press releaseA 20% increase in survival through early diagnosis: biotechnology accelerates change in th...
Low-dose CT screening can significantly reduce mortality and increase patient survival by around 20%, according to international scientific evidence Biotechnology is revolutionising lung cancer
-
NewChronic Inflammation: A Key Factor in the Threat to Healthy Aging and Healthy Living
Recent research links persistent inflammatory status to metabolic, neurodegenerative and cardiovascular pathologies.
-
CompanyVIROFEND THERAPEUTICS S.L.
-
CompanyTETRANEURON
-
CompanyLOEC INNOVATIONS, S.L.
-
NewORYZON reports financial results and corporate update for quarter ended September 30, 2025
The net result as of September 30, 2025 improved by $1.1M compared to September 2024, following termination of a Convertible Bonds financing facility with Nice&Green
-
NewAseBio participates in the public consultation of the upcoming Biotech Act with proposals ...
Harmonizing regulation, improving access to funding and talent, advancing biomanufacturing and artificial intelligence, and strengthening Europe’s strategic autonomy to build a more competitive
-
NewBIOLAN awarded the 2024 National Innovation Prize, presented by queen Letizia
The Bizkaia-based biotechnology company received the award at the Royal Palace of El Pardo (Madrid), at a ceremony presided over by Queen Letizia
-
New#NewAseBioMember | "AseBio is a meeting point for the sector and a platform for the Spanis...
Meet our new member Cencora Pharmalex. We spoke with Gonzalo Casino Fernández, Director General Cencora Pharmalex Iberia.
-
-
EventRESI Europe
-
-
NewTheriva™ Biologics Announces Presentation Describing Next Generation Oncolytic Adenovirus ...
Preclinical data for VCN-12, the next candidate from Theriva’s VCN-X discovery program, highlight a novel mechanism of action with the potential to significantly improve antitumor effects
